Page 22 - GPD-2-3
P. 22

Gene & Protein in Disease                                           Signatures construction strategies for TC






                 References  Zhang   et al., 2019 [43]  Li et al.,   2017 [41]  Luo et al.,   2017 [42]  You et al.,   2018 [33]  Liu et al.,   2018 [11]  Chengfeng   et al., 2019 [44]  Teng   et al., 2018 [21]  Saftencu   et al., 2019 [37]  Zhang   et al., 2020 [55]  Zhang   et al., 2020 [55]  (Cont’d...)



                 Multivariate Cox analysis  P‑value  HR (95% CI)  P=0.034  1.131   (1.01 – 1.267)  P=0.008  7.092   (1.667 – 30.179)  P=0.034  0.11   (0.014 – 0.845)  P=0.0338  9.28   (1.19 – 72.58)










                 Univariate Cox analysis  P‑value  HR (95% CI)  P=0.004 1.094 (1.028 –   1.163)  P<0.001 8.592 (2.878 –   25.651)  P=0.004 19.091 (2.519   – 144.674)  P<0.05  4.39 (1.24 –   15.57)  P=0.0172 11.81 (1.55 –   89.93)










                 Signature   outcome  Unfavorable  Unfavorable  Unfavorable  Unfavorable  Unfavorable  Unfavorable  Unfavorable  Unfavorable



                 AUC of the ROC   curve  0.862  0.833  0.739  0.784  0.886       AUC values for   predicting 5-year   and 10-year   survival: 0.894   and 0.957  AUC values for   predicting 5-year   and 10-year   survival: 0.843   and 0.89






                 Survival curve  P‑value  P=0.0001627  P=0.016  P<0.001  P=0.022  P=0.003  P=0.00006  P=0.012  P=0.00244





                 Survival   event  OS  OS     OS   OS   OS  OS       DFS    DFS  OS        OS


                      DOCK9-DT, LINC00900,    AC079630.2, CRNDE,   and CTD-2171N6.1  PRSS3P2, KRTAP5-AS1,   Has-miR-181a-2-3p and   hsa‐mir‐6730, hsa‐  mir‐196a‐2, and hsa‐  ITGA10 and MSLN  Lnc2mi1m2 (DIO3OS,   MLIP-AS1, has-mir-96,   Lnc5m4 (AC006487.1,   DGUOK-AS1, TLR8-AS1,   AC024563.1, ALPL,   GALNT7, ARMCX6,





                 Signature  C8orf34-AS1,   LINC01736,   ATP2C2-AS1,   FAM111A-DT,   LINC02550, and   LINC01896  RP11-536N17.1,   RP11-508M8.1,   AC026150.8, and   CTD-2139B15.2  and PWAR5  has-miR-138-1-3p  Has-mir‐6843,   mir‐206  HIGD1B, SDPR,   PACERR, and   CYP4A22-AS1  CADM2, TPPP)  AC022148.1,   IL11)




             Table 1. (Continued)  Signature   Author  type  lncRNA Yun Zhang,   et al., 2019  lncRNA  Qiuying Li,   et al., 2017 a  lncRNA Yihuan Luo,   et al., 2017  lncRNA  Xin You,   et al., 2018  miRNA  Tong Liu,   et al., 2018  miRNA  Chengfeng   Xiong,   et al., 2019  mRNA/ Huajing Teng,   lncRNA  et al., 2018  mRNA/ Mihai Saftencu,   miRNA  et al., 2019  mRNA/ Xiaoping Li,   miRNA/  et al., 2020  lncRNA  mRNA/  lncRNA











            Volume 2 Issue 3 (2023)                         6                        https://doi.org/10.36922/gpd.1138
   17   18   19   20   21   22   23   24   25   26   27